A Missouri judge on Friday approved Bayer's $7.25 billion settlement of lawsuits alleging that its weedkiller Roundup causes cancer, a decision that could ultimately resolve litigation that has weighed on the company for close to a decade.
Judge Timothy Boyer of a state court in St. Louis found the settlement "fair, reasonable, and adequate," rejecting objections to the nationwide class agreement covering current and future Roundup claims against Monsanto.
The settlement, announced in February, aims to resolve nearly all current and future Roundup claims in the United States. It covers people who allege exposure to Roundup before February 17, 2026, including those already diagnosed with non-Hodgkin lymphoma and those diagnosed within a 16-year period following final approval.
Participants could receive average payouts ranging from $10,000 to $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness. To fund the settlement, Monsanto will make declining capped annual payments for up to 21 years totaling up to $7.25 billion, inclusive of payments already made.
In his written judgment, Judge Boyer said the average individual payouts are "fair and adequate" and that the total amount is "among the largest in the history of mass tort personal-injury class action settlements."
Bayer chief executive Bill Anderson called the court-approved settlement "a decisive milestone in the company's strategy to mitigate the risks of both pending and future Roundup litigation."
The approval came five months after the U.S. Supreme Court ruled in June that Bayer cannot be sued in state courts on claims it failed to warn about cancer, because federal regulations do not require a cancer warning label and states are forbidden from imposing additional labeling requirements. The high court overturned a $1.25 million jury award for a Missouri man, John Durnell, who blamed years of exposure to glyphosate in Roundup for his non-Hodgkin lymphoma — undercutting a central claim in many of the lawsuits.
The court's final approval order is subject to appeal.


